Naranjo L, Ostos F, Gil-Etayo F, Hernandez-Gallego J, Cabrera-Marante O, Pleguezuelo D
Front Cardiovasc Med. 2021; 8:665741.
PMID: 34012984
PMC: 8126615.
DOI: 10.3389/fcvm.2021.665741.
Islam M, Alam F, Kamal M, Gan S, Sasongko T, Wong K
Front Aging Neurosci. 2017; 9:250.
PMID: 28824414
PMC: 5539075.
DOI: 10.3389/fnagi.2017.00250.
Noureldine M, Haydar A, Berjawi A, Elnawar R, Sweid A, Khamashta M
Immunol Res. 2016; 65(1):230-241.
PMID: 27423434
DOI: 10.1007/s12026-016-8831-9.
Carecchio M, Cantello R, Comi C
J Immunol Res. 2014; 2014:239398.
PMID: 24741580
PMC: 3987798.
DOI: 10.1155/2014/239398.
Kaichi Y, Kakeda S, Moriya J, Ohnari N, Saito K, Tanaka Y
AJNR Am J Neuroradiol. 2013; 35(1):100-5.
PMID: 23886740
PMC: 7966497.
DOI: 10.3174/ajnr.A3645.
Antiphospholipid syndrome presenting as progressive neuropsychiatric disorders: two case reports.
Li C, Chou M, Liu C, Lai C
Neuropsychiatr Dis Treat. 2013; 9:739-42.
PMID: 23723705
PMC: 3666907.
DOI: 10.2147/NDT.S44140.
Cognitive dysfunction and antiphospholipid antibodies.
Appenzeller S, Lapa A, de Carvalho J, Peres F, Shoenfeld Y
Curr Rheumatol Rep. 2011; 14(1):95-8.
PMID: 22134844
DOI: 10.1007/s11926-011-0224-4.
Brain magnetic resonance imaging in newly diagnosed systemic lupus erythematosus.
Petri M, Naqibuddin M, Carson K, Wallace D, Weisman M, Holliday S
J Rheumatol. 2008; 35(12):2348-54.
PMID: 18793003
PMC: 5278777.
DOI: 10.3899/jrheum.071010.
Reversible dementia in systemic lupus erythematosus without antiphospholipid antibodies or cerebral infarction.
Lee S, Jeon H, Yoo W
Rheumatol Int. 2004; 24(5):305-8.
PMID: 14997339
DOI: 10.1007/s00296-003-0405-1.
[Antiphospholipid antibody syndrome].
Schmidt R, Scheuermann E, Viertel A, Geiger H, Scharrer I
Med Klin (Munich). 1999; 94(2):93-100.
PMID: 10194954
PMC: 7095803.
DOI: 10.1007/BF03044707.
Conformationally altered beta 2-glycoprotein I is the antigen for anti-cardiolipin autoantibodies.
Chamley L, Duncalf A, Konarkowska B, Mitchell M, Johnson P
Clin Exp Immunol. 1999; 115(3):571-6.
PMID: 10193436
PMC: 1905254.
DOI: 10.1046/j.1365-2249.1999.00810.x.
Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.
Ziporen L, Shoenfeld Y, Levy Y, Korczyn A
J Clin Invest. 1997; 100(3):613-9.
PMID: 9239409
PMC: 508229.
DOI: 10.1172/JCI119572.
Antiphospholipid antibodies syndrome and cerebral ischemia.
Severi S, Ghezzi M, Felici M, Miele A
Ital J Neurol Sci. 1993; 14(2):129-37.
PMID: 8509268
DOI: 10.1007/BF02335747.
Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).
Asherson R, Denburg S, Denburg J, Carbotte R, Futrell N
Postgrad Med J. 1993; 69(814):602-8.
PMID: 8234102
PMC: 2399680.
DOI: 10.1136/pgmj.69.814.602.
The antiphospholipid syndrome.
Hughes G, Khamashta M
J R Coll Physicians Lond. 1994; 28(4):301-4.
PMID: 7965966
PMC: 5401071.
Controversies in lupus: nervous system involvement.
Bruyn G
Ann Rheum Dis. 1995; 54(3):159-67.
PMID: 7748011
PMC: 1005546.
DOI: 10.1136/ard.54.3.159.
Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate.
Valesini G, Priori R, Francia A, BALESTRIERI G, Tincani A, Airo P
Springer Semin Immunopathol. 1994; 16(2-3):313-21.
PMID: 7716711
DOI: 10.1007/BF00197524.
Aortic occlusion in systemic lupus erythematosus associated with antiphospholipid antibodies.
Drew P, Asherson R, Zuk R, Goodwin F, Hughes G
Ann Rheum Dis. 1987; 46(8):612-6.
PMID: 3116955
PMC: 1002209.
DOI: 10.1136/ard.46.8.612.
Systemic lupus erythematosus.
Hughes G
Postgrad Med J. 1988; 64(753):517-21.
PMID: 3074284
PMC: 2428894.
DOI: 10.1136/pgmj.64.753.517.
Encephalopathy, deafness and blindness in young women: a distinct retinocochleocerebral arteriolopathy?.
Asherson R, GLEDHILL R
J Neurol Neurosurg Psychiatry. 1989; 52(8):1020-1.
PMID: 2795064
PMC: 1031857.
DOI: 10.1136/jnnp.52.8.1020-a.